改善心力衰竭黑人患者治疗结果的五大考虑因素:初级保健临床医生指南
JaNae' Richard1, Jacob Sama2, Anekwe Onwuanyi3
1Department of Cardiovascular Medicine, Ochsner Louisiana State University, Shreveport, LA, USA.
Journal of the National Medical Association
|December 9, 2023
概括
黑人患者面临更糟糕的心力衰竭结果和更高的死亡率. 解决社会决定因素和改善指导方针导向治疗对于公平的护理和更好的长寿至关重要.
科学领域:
- 心脏病学 心脏病学
- 健康差异 在健康上的差异
- 公共卫生 公共卫生
背景情况:
- 与美国的其他种族/族群相比,黑人患者心力衰竭的发病时间更早,结果更差,包括死亡率更高.
- 尽管心力衰竭疗法取得了进展,但这些差异仍然存在,这些差异与诸如心血管风险更高,低于最佳指导方针的医疗疗使用以及延迟的高级护理转诊等因素有关.
研究的目的:
- 审查黑人患者心力衰竭结果中持续存在的种族差异.
- 提出基于证据的解决方案,并为初级保健医生提供一个框架来解决这些差异.
- 促进公平的治疗分配,改善心力衰竭的黑人患者的寿命.
主要方法:
- 本综述综合了有关心力衰竭种族差异的现有文献.
- 它检查了促进因素,包括健康的社会和结构性决定因素.
- 它提出了可行的,基于证据的初级保健策略.
主要成果:
- 确定了导致更糟糕结果的关键因素:较高的心血管风险,未充分利用指导方针导向的医学治疗,以及延迟获得先进治疗的机会.
- 强调急需采取干预措施,解决健康和医疗保健偏见的社会和结构性决定因素.
- 强调了质量改善计划,早期诊断和预防的作用.
结论:
- 战略干预对于弥合心力衰竭护理中的种族/民族差异差距至关重要.
- 为初级保健医生提出了一个框架,以促进公平,并改善所有心力衰竭患者的结果.
- 解决系统不平等问题和实施有针对性的计划可以提高心力衰竭的黑人患者的寿命和生活质量.
相关概念视频
Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Errors occurring during blood pressure monitoring
733
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
733
Factors affecting Blood pressure
3.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.2K
Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343


